Fate Therapeutics Has Promising Off-The-Shelf Cell Therapies While Looking Cheap

Fate Therapeutics (NASDAQ: FATE ) is a biopharma microcap working on cellular therapies. The company was originally focused on oncology applications with its technology, but it recently pivoted toward a less crowded market in immunology. Currently, FATE leverages induced pluripotent stem cells [iPSCs] and otherMy name is Myriam Hernandez Alvarez. I received the Electronics and Telecommunication Engineering degree from the Escuela Politecnica Nacional, Quito, Ecuador, the M.Sc. degree in computer science fro ...